| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 632 | 2.915 | 255 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 0 | 43.659 | 632 | 2.915 | 255 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | 225 | 19.445 | 22.493 | 11.634 | 7.976 | 5.098 | 5.061 | 0 |
| Gross Profit/Loss - EUR | - | - | -225 | 24.214 | -21.861 | -8.719 | -7.721 | -5.098 | -5.061 | 0 |
| Net Profit/Loss - EUR | - | - | -225 | 24.214 | -21.861 | -8.748 | -7.724 | -5.098 | -5.061 | 0 |
| Employees | - | - | 1 | 3 | 3 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Ortorem Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 44.502 | 38.306 | 32.288 | 26.500 | 20.851 | 15.839 | 10.730 | 10.670 |
| Current Assets | - | - | 44 | 65 | 64 | 63 | 316 | 41 | 40 | 0 |
| Inventories | - | - | 0 | 22 | 22 | 22 | 21 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 255 | 0 | 0 | 0 |
| Cash | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 0 |
| Shareholders Funds | - | - | -181 | 24.036 | 1.710 | -7.070 | -14.637 | -19.780 | -24.782 | -24.643 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 44.727 | 14.335 | 30.642 | 33.633 | 35.805 | 35.660 | 35.552 | 35.313 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ortorem Med S.r.l.